Posts for IMMUNIC, INC. ($IMUX)

Explore Immunic, Inc.'s latest 8-K report detailing significant updates, stock performance, and financial context as of February 20, 2025. Essential for investors!

Explore Immunic, Inc.'s 8-K filing detailing significant corporate events, financial metrics, and insights for investors. Stay updated on NASDAQ's emerging biotech companies.

Explore Immunic, Inc.'s latest 8-K report detailing significant corporate events as of December 13, 2024. Insights on stock performance and regulatory compliance included.